Jaime Dutton, MD
Surgery · Stanford, CANPI 1861611725
Payments from drug & device makers
Across 92 payments — averaging $138.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- Baxter Healthcare$762
- Covidien LP$341
- Medtronic$218
- Avanos Medical$141
- Novo Nordisk$92
- plus $482 from 15 others
What the payments were for
- Travel & lodging$3,39927%
- Food & beverage$2,36419%
- Education$7,00055%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 21 | $10,727 |
| Baxter Healthcare | 28 | $762 |
| Covidien LP | 7 | $341 |
| Medtronic | 5 | $218 |
| Avanos Medical | 2 | $141 |
| Novo Nordisk | 6 | $92 |
| Vertex | 4 | $91 |
| Acell, Inc. | 1 | $82 |
| TELA Bio, Inc. | 1 | $57 |
| Endo Pharmaceuticals Inc. | 4 | $51 |
| W. L. Gore & Associates, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Olympus America Inc. | 1 | $20 |
| Conmed Corporation | 1 | $19 |
| Davol Inc. | 1 | $19 |
| Teleflex LLC | 1 | $18 |
| Apollo Endosurgery US Inc | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Bolder Surgical LLC | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$10,269
- Sonicision$156
- ON-Q* PUMP AND ACCESSORIES$104
- Signia$103
How this compares
$12,763 in reported general payments places this provider in the 80th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 95 | $1,573 |
| Misoprostol | 27 | $1,504 |
| Sucralfate | 21 | $451 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $384 |
| Pantoprazole Sodium | 60 | $274 |
| Promethazine Hcl | 17 | $77 |
Paid to pharmacies, not to this prescriber.
Other surgery in Stanford
- Brendan VisserStanford$592K
- Timothy ChuterSan Francisco$8.9M
- Peter StockSan Francisco$6.5M
- Santiago HorganSan Diego$2.8M
- Kenneth DeckLaguna Hills$2.4M
- Daniel RiskinSan Jose$2.2M
- Michael DemeureNewport Beach$1.7M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.